Beta Bionics: FDA Clearance Of Mint Sets Stage For 2027 Patch Pump Launch

Beta Bionics received FDA clearance for Mint, a new patch pump with reusable and disposable components. The company also submitted its next-generation 3D Intelligence insulin-dosing algorithm to the FDA via the 510(k) pathway, advancing its diabetes-device product pipeline. The clearance and new regulatory filing are positive catalysts for BBNX, though commercial timing and adoption were not disclosed.